Stakeholder Survey: RBD Treatment Symptoms and Side Effects

The purpose of this survey is to help us gain a better understanding on the treatment priorities that matter most to patients, their caregivers and medical providers. Your input will help the guideline developers make patient-centered recommendations for treating RBD.

The information you provide will only be used by American Academy of Sleep Medicine (AASM) staff and the guideline task force. We will not disclose or share your information with anyone outside of the AASM.

Thank you for helping the AASM as we develop a clinical practice guideline for the treatment of RBD.

There are 15 questions in this survey.
  A note on privacy
This survey is anonymous.
The record of your survey responses does not contain any identifying information about you, unless a specific survey question explicitly asked for it. If you used an identifying token to access this survey, please rest assured that this token will not be stored together with your responses. It is managed in a separate database and will only be updated to indicate whether you did (or did not) complete this survey. There is no way of matching identification tokens with survey responses.